| 104190-4 | Mucopolysaccharidosis type II comment Narrative (Dbs) |
| 104193-8 | Guanidinoacetate methyltransferase deficiency comment Narrative (Dbs) |
| 104935-2 | Care plan requested activity information |
| 107447-5 | Duchenne muscular dystrophy comment Narrative (Dbs) |
| 107556-3 | General comment Narrative |
| 111823-1 | Metachromatic leukodystrophy comment Narrative (Dbs) |
| 112069-0 | Immunization invitation letter Narrative Preventive medicine |
| 112071-6 | Screening invitation letter Narrative Preventive medicine |
| 18667-6 | Alcohol-substance abuse rehabilitation treatment plan, Methodology for follow up (narrative) Text |
| 18669-2 | Rehabilitation treatment plan, Level of patient participation Text |
| 18671-8 | Psychiatric rehabilitation treatment plan, Next plan of treatment (narrative) Text |
| 18822-7 | Diagnosis addressed (plan (narrative)) |
| 27466-2 | Cardiac rehabilitation treatment plan, Diagnosis addressed (plan (narrative) text) |
| 27529-7 | Alcohol-substance abuse rehabilitation treatment plan, Diagnosis addressed (plan (narrative) text) |
| 27593-3 | Skilled nursing treatment plan, Diagnosis addressed (plan (narrative) text) |
| 27644-4 | Occupational therapy treatment plan, Diagnosis addressed (plan (narrative) text) |
| 27656-8 | Physical therapy treatment plan, Diagnosis addressed (plan (narrative) text) |
| 27746-7 | Respiratory therapy treatment plan, Diagnosis addressed (plan (narrative) text) |
| 27797-0 | Medical social services treatment plan, Diagnosis addressed (plan (narrative) text) |
| 29135-1 | prescription Glasses type |
| 29138-5 | Pressure device type Perimetry |
| 29193-0 | Speech therapy treatment plan, Diagnosis addressed (plan (narrative) text) |
| 39217-5 | Other screen name CPHS |
| 39223-3 | Diagnosis recommendations, description (narrative) CPHS |
| 39233-2 | Screen test, other name CPHS |
| 39251-4 | Other program participation name CPHS |
| 39275-3 | Follow-up (referred to) program, name CPHS |
| 39287-8 | Patient escort, other escort relationship (narrative) CPHS |
| 47998-0 | DNA sequence variation display name Narrative |
| 52105-4 | Alcohol-substance abuse rehabilitation treatment plan, Next plan of treatment (narrative) Text |
| 53577-3 | Reason for study |
| 57699-1 | Biotinidase deficiency newborn screening comment-discussion |
| 57700-7 | Hearing loss newborn screening comment/discussion |
| 57701-5 | Infectious diseases newborn screening comment-discussion |
| 57703-1 | Hemoglobin disorders newborn screening comment-discussion |
| 57704-9 | Galactosemias newborn screening comment-discussion |
| 57705-6 | Congenital hypothyroidism newborn screening comment-discussion |
| 57706-4 | Congenital adrenal hyperplasia newborn screening comment-discussion |
| 57707-2 | Cystic fibrosis newborn screening comment-discussion |
| 57708-0 | Organic acidemias defects newborn screening comment-discussion |
| 57709-8 | Fatty acid oxidation defects newborn screening comment-discussion |
| 57710-6 | Amino acidemias newborn screening comment-discussion |
| 57724-7 | Newborn screening short narrative summary |
| 58090-2 | Glucose-6-Phosphate dehydrogenase newborn screening comment-discussion |
| 58093-6 | Acylcarnitine newborn screening comment-discussion |
| 58230-4 | Maple syrup urine disease newborn screening comment-discussion |
| 58231-2 | Phenylketonuria and variants/Biopterin defects newborn screening comment-discussion |
| 62303-3 | Lysosomal storage disorders newborn screening comment-discussion |
| 62306-6 | Fabry disease newborn screening comment-discussion |
| 62309-0 | Krabbe disease newborn screening comment-discussion |
| 62313-2 | Gaucher disease newborn screening comment-discussion |
| 62319-9 | Niemann Pick disease A/B newborn screening comment-discussion |
| 62322-3 | Severe combined immunodeficiency newborn screening comment-discussion |
| 63416-2 | Pompe disease newborn screening comment-discussion |
| 65936-7 | Age and mode of onset notes |
| 65938-3 | Psychological stressor notes |
| 65942-5 | Premorbid adjustment notes |
| 65944-1 | Coarse brain disorder notes |
| 65947-4 | Family history notes |
| 65950-8 | Dysphoria notes |
| 65952-4 | Anhedonia notes |
| 65958-1 | Depressive symptom notes |
| 65960-7 | Suicidality notes |
| 65972-2 | Appetite or sleep change notes |
| 65975-5 | Elevated or irritable mood notes |
| 65984-7 | Hypomanic or manic symptom notes |
| 65986-2 | Any modality hallucinations notes |
| 65991-2 | Hallucination notes |
| 65996-1 | Subjective thought disturbance notes |
| 66008-4 | Delusion notes |
| 66011-8 | Insight or relationship between psychotic and affective symptom notes |
| 66288-2 | Problem with 7 days interview Observer |
| 66290-8 | Reason not a valid 7 days PAR interview Observer |
| 66328-6 | Activity while not wearing monitor |
| 69446-3 | Injury date comment |
| 69969-4 | Newborn screening report overall laboratory comment |
| 75545-4 | Noninvasive prenatal testing comment |
| 75553-8 | Comment on fetal Trisomy 13 risk cell-free+WBC DNA (dosage of chromosome-specific cfdna narrative) |
| 75559-5 | Comment on fetal Trisomy 18 risk cell-free+WBC DNA (dosage of chromosome-specific cfdna narrative) |
| 75565-2 | Comment on fetal Trisomy 21 risk cell-free+WBC DNA (dosage of chromosome-specific cfdna narrative) |
| 75571-0 | Comment on fetal Monosomy X risk cell-free+WBC DNA (dosage of chromosome-specific cfdna narrative) |
| 75579-3 | Comment on fetal 22q11.2 deletion risk cell-free+WBC DNA (dosage of chromosome-specific cfdna narrative) |
| 75585-0 | Comment on fetal Prader-Willi syndrome risk cell-free+WBC DNA (dosage of chromosome-specific cfdna narrative) |
| 75591-8 | Comment on fetal Angelman syndrome risk cell-free+WBC DNA (dosage of chromosome-specific cfdna narrative) |
| 75597-5 | Comment on fetal 5p deletion risk cell-free+WBC DNA (dosage of chromosome-specific cfdna narrative) |
| 75603-1 | Comment on fetal 1p36 deletion risk cell-free+WBC DNA (dosage of chromosome-specific cfdna narrative) |
| 76662-6 | Instructions Medication Narrative |
| 77202-0 | Laboratory comment in Report Narrative |
| 79565-8 | Mucopolysaccharidosis type I newborn screening comment-discussion |
| 81293-3 | Description of ranges of DNA sequences examined |
| 85268-1 | X-linked adrenoleukodystrophy newborn screening comment-discussion |
| 92003-3 | Spinal muscular atrophy newborn screening comment-discussion |
| 96980-8 | Comment on overall fetal aneuploidy risk cell-free+WBC DNA (dosage of chromosome-specific cfdna narrative) |